ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Poultry Live Attenuated Vaccine Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-19H16815
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Poultry Live Attenuated Vaccine Market Research Report 2024
BUY CHAPTERS

Global Poultry Live Attenuated Vaccine Market Research Report 2025

Code: QYRE-Auto-19H16815
Report
September 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Boehringer Ingelheim
Ceva
Zoetis Inc
Vaxxinova
Elanco
QYH Biotech
Pulike
Phibro Animal Health Corporation
Harbin Pharmaceutical Group
MEVAC
Venky's
Dechra

Poultry Live Attenuated Vaccine Market Size

The global market for Poultry Live Attenuated Vaccine was valued at US$ 2193 million in the year 2024 and is projected to reach a revised size of US$ 2707 million by 2031, growing at a CAGR of 3.1% during the forecast period.

Poultry Live Attenuated Vaccine Market

Poultry Live Attenuated Vaccine Market

Poultry live attenuated vaccines are a type of vaccine used in the poultry industry to protect birds from various infectious diseases. Live attenuated vaccines contain weakened or modified forms of the pathogen that causes the disease, allowing the bird"s immune system to develop a protective response without causing severe illness.
North American market for Poultry Live Attenuated Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Poultry Live Attenuated Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Poultry Live Attenuated Vaccine include MERCK, Boehringer Ingelheim, CEVA, ZOETIS, Vaxxinova, ELANCO, QYH BIOTECH, PULIKE, PHIBRO ANIMAL HEALTH CORPORATION, HARBIN PHARMACEUTICAL GROUP, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Poultry Live Attenuated Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poultry Live Attenuated Vaccine.
The Poultry Live Attenuated Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Poultry Live Attenuated Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Poultry Live Attenuated Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Poultry Live Attenuated Vaccine Market Report

Report Metric Details
Report Name Poultry Live Attenuated Vaccine Market
Accounted market size in year US$ 2193 million
Forecasted market size in 2031 US$ 2707 million
CAGR 3.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • NDV
  • Marek ' s Disease
  • IBD
  • Infectious Bronchitis
  • Influenza
  • Other
Segment by Application
  • Chicken
  • Other Poultry
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company MERCK, Boehringer Ingelheim, CEVA, ZOETIS, Vaxxinova, ELANCO, QYH BIOTECH, PULIKE, PHIBRO ANIMAL HEALTH CORPORATION, HARBIN PHARMACEUTICAL GROUP, MEVAC, VENKY’S, Dechra
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Poultry Live Attenuated Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Poultry Live Attenuated Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Poultry Live Attenuated Vaccine Market growing?

Ans: The Poultry Live Attenuated Vaccine Market witnessing a CAGR of 3.1% during the forecast period 2025-2031.

What is the Poultry Live Attenuated Vaccine Market size in 2031?

Ans: The Poultry Live Attenuated Vaccine Market size in 2031 will be US$ 2707 million.

Who are the main players in the Poultry Live Attenuated Vaccine Market report?

Ans: The main players in the Poultry Live Attenuated Vaccine Market are MERCK, Boehringer Ingelheim, CEVA, ZOETIS, Vaxxinova, ELANCO, QYH BIOTECH, PULIKE, PHIBRO ANIMAL HEALTH CORPORATION, HARBIN PHARMACEUTICAL GROUP, MEVAC, VENKY’S, Dechra

What are the Application segmentation covered in the Poultry Live Attenuated Vaccine Market report?

Ans: The Applications covered in the Poultry Live Attenuated Vaccine Market report are Chicken, Other Poultry

What are the Type segmentation covered in the Poultry Live Attenuated Vaccine Market report?

Ans: The Types covered in the Poultry Live Attenuated Vaccine Market report are NDV, Marek ' s Disease, IBD, Infectious Bronchitis, Influenza, Other

1 Poultry Live Attenuated Vaccine Market Overview
1.1 Product Definition
1.2 Poultry Live Attenuated Vaccine by Type
1.2.1 Global Poultry Live Attenuated Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 NDV
1.2.3 Marek ' s Disease
1.2.4 IBD
1.2.5 Infectious Bronchitis
1.2.6 Influenza
1.2.7 Other
1.3 Poultry Live Attenuated Vaccine by Application
1.3.1 Global Poultry Live Attenuated Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Chicken
1.3.3 Other Poultry
1.4 Global Poultry Live Attenuated Vaccine Market Size Estimates and Forecasts
1.4.1 Global Poultry Live Attenuated Vaccine Revenue 2020-2031
1.4.2 Global Poultry Live Attenuated Vaccine Sales 2020-2031
1.4.3 Global Poultry Live Attenuated Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Poultry Live Attenuated Vaccine Market Competition by Manufacturers
2.1 Global Poultry Live Attenuated Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Poultry Live Attenuated Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Poultry Live Attenuated Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Poultry Live Attenuated Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Poultry Live Attenuated Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Poultry Live Attenuated Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Poultry Live Attenuated Vaccine, Date of Enter into This Industry
2.8 Global Poultry Live Attenuated Vaccine Market Competitive Situation and Trends
2.8.1 Global Poultry Live Attenuated Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Poultry Live Attenuated Vaccine Players Market Share by Revenue
2.8.3 Global Poultry Live Attenuated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Poultry Live Attenuated Vaccine Market Scenario by Region
3.1 Global Poultry Live Attenuated Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Poultry Live Attenuated Vaccine Sales by Region: 2020-2031
3.2.1 Global Poultry Live Attenuated Vaccine Sales by Region: 2020-2025
3.2.2 Global Poultry Live Attenuated Vaccine Sales by Region: 2026-2031
3.3 Global Poultry Live Attenuated Vaccine Revenue by Region: 2020-2031
3.3.1 Global Poultry Live Attenuated Vaccine Revenue by Region: 2020-2025
3.3.2 Global Poultry Live Attenuated Vaccine Revenue by Region: 2026-2031
3.4 North America Poultry Live Attenuated Vaccine Market Facts & Figures by Country
3.4.1 North America Poultry Live Attenuated Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Poultry Live Attenuated Vaccine Sales by Country (2020-2031)
3.4.3 North America Poultry Live Attenuated Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Poultry Live Attenuated Vaccine Market Facts & Figures by Country
3.5.1 Europe Poultry Live Attenuated Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Poultry Live Attenuated Vaccine Sales by Country (2020-2031)
3.5.3 Europe Poultry Live Attenuated Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Poultry Live Attenuated Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Poultry Live Attenuated Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Poultry Live Attenuated Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Poultry Live Attenuated Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Poultry Live Attenuated Vaccine Market Facts & Figures by Country
3.7.1 Latin America Poultry Live Attenuated Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Poultry Live Attenuated Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Poultry Live Attenuated Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Poultry Live Attenuated Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Poultry Live Attenuated Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Poultry Live Attenuated Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Poultry Live Attenuated Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Poultry Live Attenuated Vaccine Sales by Type (2020-2031)
4.1.1 Global Poultry Live Attenuated Vaccine Sales by Type (2020-2025)
4.1.2 Global Poultry Live Attenuated Vaccine Sales by Type (2026-2031)
4.1.3 Global Poultry Live Attenuated Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Poultry Live Attenuated Vaccine Revenue by Type (2020-2031)
4.2.1 Global Poultry Live Attenuated Vaccine Revenue by Type (2020-2025)
4.2.2 Global Poultry Live Attenuated Vaccine Revenue by Type (2026-2031)
4.2.3 Global Poultry Live Attenuated Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Poultry Live Attenuated Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Poultry Live Attenuated Vaccine Sales by Application (2020-2031)
5.1.1 Global Poultry Live Attenuated Vaccine Sales by Application (2020-2025)
5.1.2 Global Poultry Live Attenuated Vaccine Sales by Application (2026-2031)
5.1.3 Global Poultry Live Attenuated Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Poultry Live Attenuated Vaccine Revenue by Application (2020-2031)
5.2.1 Global Poultry Live Attenuated Vaccine Revenue by Application (2020-2025)
5.2.2 Global Poultry Live Attenuated Vaccine Revenue by Application (2026-2031)
5.2.3 Global Poultry Live Attenuated Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Poultry Live Attenuated Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 MERCK
6.1.1 MERCK Company Information
6.1.2 MERCK Description and Business Overview
6.1.3 MERCK Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 MERCK Poultry Live Attenuated Vaccine Product Portfolio
6.1.5 MERCK Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Company Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boehringer Ingelheim Poultry Live Attenuated Vaccine Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 CEVA
6.3.1 CEVA Company Information
6.3.2 CEVA Description and Business Overview
6.3.3 CEVA Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CEVA Poultry Live Attenuated Vaccine Product Portfolio
6.3.5 CEVA Recent Developments/Updates
6.4 ZOETIS
6.4.1 ZOETIS Company Information
6.4.2 ZOETIS Description and Business Overview
6.4.3 ZOETIS Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 ZOETIS Poultry Live Attenuated Vaccine Product Portfolio
6.4.5 ZOETIS Recent Developments/Updates
6.5 Vaxxinova
6.5.1 Vaxxinova Company Information
6.5.2 Vaxxinova Description and Business Overview
6.5.3 Vaxxinova Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Vaxxinova Poultry Live Attenuated Vaccine Product Portfolio
6.5.5 Vaxxinova Recent Developments/Updates
6.6 ELANCO
6.6.1 ELANCO Company Information
6.6.2 ELANCO Description and Business Overview
6.6.3 ELANCO Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 ELANCO Poultry Live Attenuated Vaccine Product Portfolio
6.6.5 ELANCO Recent Developments/Updates
6.7 QYH BIOTECH
6.7.1 QYH BIOTECH Company Information
6.7.2 QYH BIOTECH Description and Business Overview
6.7.3 QYH BIOTECH Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 QYH BIOTECH Poultry Live Attenuated Vaccine Product Portfolio
6.7.5 QYH BIOTECH Recent Developments/Updates
6.8 PULIKE
6.8.1 PULIKE Company Information
6.8.2 PULIKE Description and Business Overview
6.8.3 PULIKE Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 PULIKE Poultry Live Attenuated Vaccine Product Portfolio
6.8.5 PULIKE Recent Developments/Updates
6.9 PHIBRO ANIMAL HEALTH CORPORATION
6.9.1 PHIBRO ANIMAL HEALTH CORPORATION Company Information
6.9.2 PHIBRO ANIMAL HEALTH CORPORATION Description and Business Overview
6.9.3 PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Product Portfolio
6.9.5 PHIBRO ANIMAL HEALTH CORPORATION Recent Developments/Updates
6.10 HARBIN PHARMACEUTICAL GROUP
6.10.1 HARBIN PHARMACEUTICAL GROUP Company Information
6.10.2 HARBIN PHARMACEUTICAL GROUP Description and Business Overview
6.10.3 HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Product Portfolio
6.10.5 HARBIN PHARMACEUTICAL GROUP Recent Developments/Updates
6.11 MEVAC
6.11.1 MEVAC Company Information
6.11.2 MEVAC Description and Business Overview
6.11.3 MEVAC Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 MEVAC Poultry Live Attenuated Vaccine Product Portfolio
6.11.5 MEVAC Recent Developments/Updates
6.12 VENKY’S
6.12.1 VENKY’S Company Information
6.12.2 VENKY’S Description and Business Overview
6.12.3 VENKY’S Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 VENKY’S Poultry Live Attenuated Vaccine Product Portfolio
6.12.5 VENKY’S Recent Developments/Updates
6.13 Dechra
6.13.1 Dechra Company Information
6.13.2 Dechra Description and Business Overview
6.13.3 Dechra Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Dechra Poultry Live Attenuated Vaccine Product Portfolio
6.13.5 Dechra Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Poultry Live Attenuated Vaccine Industry Chain Analysis
7.2 Poultry Live Attenuated Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Poultry Live Attenuated Vaccine Production Mode & Process Analysis
7.4 Poultry Live Attenuated Vaccine Sales and Marketing
7.4.1 Poultry Live Attenuated Vaccine Sales Channels
7.4.2 Poultry Live Attenuated Vaccine Distributors
7.5 Poultry Live Attenuated Vaccine Customer Analysis
8 Poultry Live Attenuated Vaccine Market Dynamics
8.1 Poultry Live Attenuated Vaccine Industry Trends
8.2 Poultry Live Attenuated Vaccine Market Drivers
8.3 Poultry Live Attenuated Vaccine Market Challenges
8.4 Poultry Live Attenuated Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
Boehringer Ingelheim
Ceva
Zoetis Inc
Vaxxinova
Elanco
QYH Biotech
Pulike
Phibro Animal Health Corporation
Harbin Pharmaceutical Group
MEVAC
Venky's
Dechra
List of Tables
 Table 1. Global Poultry Live Attenuated Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Poultry Live Attenuated Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Poultry Live Attenuated Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Poultry Live Attenuated Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Poultry Live Attenuated Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Poultry Live Attenuated Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Poultry Live Attenuated Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Poultry Live Attenuated Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Poultry Live Attenuated Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Poultry Live Attenuated Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Poultry Live Attenuated Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Poultry Live Attenuated Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Poultry Live Attenuated Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poultry Live Attenuated Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Poultry Live Attenuated Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Poultry Live Attenuated Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Poultry Live Attenuated Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Poultry Live Attenuated Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Poultry Live Attenuated Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Poultry Live Attenuated Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Poultry Live Attenuated Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Poultry Live Attenuated Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Poultry Live Attenuated Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Poultry Live Attenuated Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Poultry Live Attenuated Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Poultry Live Attenuated Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Poultry Live Attenuated Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Poultry Live Attenuated Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Poultry Live Attenuated Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Poultry Live Attenuated Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Poultry Live Attenuated Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Poultry Live Attenuated Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Poultry Live Attenuated Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Poultry Live Attenuated Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Poultry Live Attenuated Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Poultry Live Attenuated Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Poultry Live Attenuated Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Poultry Live Attenuated Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Poultry Live Attenuated Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Poultry Live Attenuated Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Poultry Live Attenuated Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Poultry Live Attenuated Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Poultry Live Attenuated Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Poultry Live Attenuated Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Poultry Live Attenuated Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Poultry Live Attenuated Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Poultry Live Attenuated Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Poultry Live Attenuated Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Poultry Live Attenuated Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Poultry Live Attenuated Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Poultry Live Attenuated Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Poultry Live Attenuated Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Poultry Live Attenuated Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Poultry Live Attenuated Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Poultry Live Attenuated Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Poultry Live Attenuated Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Poultry Live Attenuated Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Poultry Live Attenuated Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Poultry Live Attenuated Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Poultry Live Attenuated Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Poultry Live Attenuated Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Poultry Live Attenuated Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Poultry Live Attenuated Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Poultry Live Attenuated Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Poultry Live Attenuated Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Poultry Live Attenuated Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Poultry Live Attenuated Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Poultry Live Attenuated Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. MERCK Company Information
 Table 71. MERCK Description and Business Overview
 Table 72. MERCK Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. MERCK Poultry Live Attenuated Vaccine Product
 Table 74. MERCK Recent Developments/Updates
 Table 75. Boehringer Ingelheim Company Information
 Table 76. Boehringer Ingelheim Description and Business Overview
 Table 77. Boehringer Ingelheim Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Boehringer Ingelheim Poultry Live Attenuated Vaccine Product
 Table 79. Boehringer Ingelheim Recent Developments/Updates
 Table 80. CEVA Company Information
 Table 81. CEVA Description and Business Overview
 Table 82. CEVA Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. CEVA Poultry Live Attenuated Vaccine Product
 Table 84. CEVA Recent Developments/Updates
 Table 85. ZOETIS Company Information
 Table 86. ZOETIS Description and Business Overview
 Table 87. ZOETIS Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. ZOETIS Poultry Live Attenuated Vaccine Product
 Table 89. ZOETIS Recent Developments/Updates
 Table 90. Vaxxinova Company Information
 Table 91. Vaxxinova Description and Business Overview
 Table 92. Vaxxinova Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Vaxxinova Poultry Live Attenuated Vaccine Product
 Table 94. Vaxxinova Recent Developments/Updates
 Table 95. ELANCO Company Information
 Table 96. ELANCO Description and Business Overview
 Table 97. ELANCO Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. ELANCO Poultry Live Attenuated Vaccine Product
 Table 99. ELANCO Recent Developments/Updates
 Table 100. QYH BIOTECH Company Information
 Table 101. QYH BIOTECH Description and Business Overview
 Table 102. QYH BIOTECH Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. QYH BIOTECH Poultry Live Attenuated Vaccine Product
 Table 104. QYH BIOTECH Recent Developments/Updates
 Table 105. PULIKE Company Information
 Table 106. PULIKE Description and Business Overview
 Table 107. PULIKE Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. PULIKE Poultry Live Attenuated Vaccine Product
 Table 109. PULIKE Recent Developments/Updates
 Table 110. PHIBRO ANIMAL HEALTH CORPORATION Company Information
 Table 111. PHIBRO ANIMAL HEALTH CORPORATION Description and Business Overview
 Table 112. PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Product
 Table 114. PHIBRO ANIMAL HEALTH CORPORATION Recent Developments/Updates
 Table 115. HARBIN PHARMACEUTICAL GROUP Company Information
 Table 116. HARBIN PHARMACEUTICAL GROUP Description and Business Overview
 Table 117. HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Product
 Table 119. HARBIN PHARMACEUTICAL GROUP Recent Developments/Updates
 Table 120. MEVAC Company Information
 Table 121. MEVAC Description and Business Overview
 Table 122. MEVAC Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. MEVAC Poultry Live Attenuated Vaccine Product
 Table 124. MEVAC Recent Developments/Updates
 Table 125. VENKY’S Company Information
 Table 126. VENKY’S Description and Business Overview
 Table 127. VENKY’S Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. VENKY’S Poultry Live Attenuated Vaccine Product
 Table 129. VENKY’S Recent Developments/Updates
 Table 130. Dechra Company Information
 Table 131. Dechra Description and Business Overview
 Table 132. Dechra Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Dechra Poultry Live Attenuated Vaccine Product
 Table 134. Dechra Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Poultry Live Attenuated Vaccine Distributors List
 Table 138. Poultry Live Attenuated Vaccine Customers List
 Table 139. Poultry Live Attenuated Vaccine Market Trends
 Table 140. Poultry Live Attenuated Vaccine Market Drivers
 Table 141. Poultry Live Attenuated Vaccine Market Challenges
 Table 142. Poultry Live Attenuated Vaccine Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Poultry Live Attenuated Vaccine
 Figure 2. Global Poultry Live Attenuated Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Poultry Live Attenuated Vaccine Market Share by Type: 2024 & 2031
 Figure 4. NDV Product Picture
 Figure 5. Marek ' s Disease Product Picture
 Figure 6. IBD Product Picture
 Figure 7. Infectious Bronchitis Product Picture
 Figure 8. Influenza Product Picture
 Figure 9. Other Product Picture
 Figure 10. Global Poultry Live Attenuated Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Poultry Live Attenuated Vaccine Market Share by Application: 2024 & 2031
 Figure 12. Chicken
 Figure 13. Other Poultry
 Figure 14. Global Poultry Live Attenuated Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Poultry Live Attenuated Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Poultry Live Attenuated Vaccine Sales (2020-2031) & (K Units)
 Figure 17. Global Poultry Live Attenuated Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 18. Poultry Live Attenuated Vaccine Report Years Considered
 Figure 19. Poultry Live Attenuated Vaccine Sales Share by Manufacturers in 2024
 Figure 20. Global Poultry Live Attenuated Vaccine Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Poultry Live Attenuated Vaccine Players: Market Share by Revenue in Poultry Live Attenuated Vaccine in 2024
 Figure 22. Poultry Live Attenuated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Poultry Live Attenuated Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Poultry Live Attenuated Vaccine Sales Market Share by Country (2020-2031)
 Figure 25. North America Poultry Live Attenuated Vaccine Revenue Market Share by Country (2020-2031)
 Figure 26. United States Poultry Live Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Poultry Live Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Poultry Live Attenuated Vaccine Sales Market Share by Country (2020-2031)
 Figure 29. Europe Poultry Live Attenuated Vaccine Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Poultry Live Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Poultry Live Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Poultry Live Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Poultry Live Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Poultry Live Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Poultry Live Attenuated Vaccine Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Poultry Live Attenuated Vaccine Revenue Market Share by Region (2020-2031)
 Figure 37. China Poultry Live Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Poultry Live Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Poultry Live Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Poultry Live Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Poultry Live Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Poultry Live Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Poultry Live Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Poultry Live Attenuated Vaccine Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Poultry Live Attenuated Vaccine Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Poultry Live Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Poultry Live Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Poultry Live Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Poultry Live Attenuated Vaccine Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Poultry Live Attenuated Vaccine Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Poultry Live Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Poultry Live Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Poultry Live Attenuated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Poultry Live Attenuated Vaccine by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Poultry Live Attenuated Vaccine by Type (2020-2031)
 Figure 56. Global Poultry Live Attenuated Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Poultry Live Attenuated Vaccine by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Poultry Live Attenuated Vaccine by Application (2020-2031)
 Figure 59. Global Poultry Live Attenuated Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 60. Poultry Live Attenuated Vaccine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Poultry Live Vaccines Market Research Report 2025
Global Live Poultry Vaccine Market Research Report 2025
Global Live type Poultry Vaccine Market Research Report 2025
Global Live Attenuated Vaccines for Pets Market Research Report 2025
Global Live Attenuated Vaccine for Pig Market Research Report 2024
Global Poultry Killed Vaccines Market Research Report 2025
Global Poultry Vaccines Market Research Report 2025
Global Poultry and Livestock Vaccines Market Research Report 2025
Global Coccidia Virus Live Vaccine Market Research Report 2025
Global Infectious Bursal Disease Vaccine Market Research Report 2024
Global Chicken Newcastle Disease Vaccine Market Research Report 2024
Varicella Virus Attenuated Live Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Live and Attenuated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Live Herpes Zoster Vaccine Market Research Report 2024
Global Nasal Spray Live Attenuated Vaccine Market Research Report 2024
Global Coccidiosis Vaccine for Chickens Market Research Report 2024
Global Live Attenuated Polio Vaccine Market Research Report 2024
Global Poultry Biological Products and Poultry Vaccines Market Research Report 2024
Global Avian Influenza Vaccines Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Poultry Coccidiosis Vaccines Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions